Skip to content

effect of IPL with and without intradermal injection of tranexamic acid in treatment of post acne Erythema

Investigation of the effect of IPL with and without intradermal injection of tranexamic acid in treatment of resistant post acne Erythema , An split face control trial in loghman hakim hospital in 1401

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221206056736N1
Enrollment
25
Registered
2023-04-17
Start date
2023-02-04
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post acne erythema. Acne vulgaris

Interventions

Intervention 1: Intervention group: On the selected side of the face, ampoules of 500mg/5ml tranexamic acid will be injected intradermally by 1cc syringes at a distance of one centimeter in the areas

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 40 Years

Inclusion criteria

Inclusion criteria: people with persistent post acne erythema that did not improve for at least 3 months in the age range of 16 to 40 years

Exclusion criteria

Exclusion criteria: coagulation disorders such as DIC ,pulmonary embolism,stroke,DVT suffering from cancers sensitivity to tranexamic acid in previous use consumption of drugs that interfere with the use of tranexamic acid (anticoagulants,estrogenic drugs,tretinoin and anti inhibitory coagulation concentrates ) pregnancy,breastfeeding and the decision to become pregnant oral and topical use of retinoids in the last 6 months prone to keloid formation photosensitivity the use of exfoliating topical drugs including AHA

Design outcomes

Primary

MeasureTime frame
Erythema improvment on the right and left side of the face. Timepoint: The beginning of the study, day 21, day 42, day 72. Method of measurement: Scale of Clinician erythema assessment.;Patient satisfaction from treatment on the right and left side compared to before. Timepoint: The beginning of the study, day 21, day 42, day 72. Method of measurement: Asking the patient to choose a number from 1 (low) to 4 (very high) ,from the level of satisfaction with the treatment on each side of face.

Secondary

MeasureTime frame
The side effects. Timepoint: The beginning of the study, day 21, day 42, day 72. Method of measurement: Questions and comparisons.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNushin Golchin

Shahid Beheshti University of Medical Sciences

Nushin.golchin@yahoo.com+98 21 4469 7518

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026